| Jeri Berger, MS, CCC-SLP | |
|
13010 Ne 20th St Ste 300, Bellevue, WA 98005-2054 | |
| (425) 644-6328 | |
| (425) 644-6295 |
| Full Name | Jeri Berger |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 13010 Ne 20th St Ste 300, Bellevue, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144999657 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL60638295 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jeri Berger, MS, CCC-SLP 5150 Village Park Dr Se, Bellevue, WA 98006-6652 Ph: (425) 657-0620 | Jeri Berger, MS, CCC-SLP 13010 Ne 20th St Ste 300, Bellevue, WA 98005-2054 Ph: (425) 644-6328 |
News Archive
Outbreaks of tuberculosis (TB) may be able to be identified by looking at certain characteristics of the first two patients, according to new research. If the first two patients are diagnosed within three months of each other, live in urban areas, and if one or both are of sub-Saharan African origin, there is a 56 percent chance that the two cases will lead to a large outbreak of TB, whereas if the patients exhibit none of those characteristics, the odds are just one percent.
For the first time, California's largest nonprofit health insurer has released the salaries of its 10 highest-paid executives in response to a new state law intended to keep health care insurance costs under control.
People with poor lung function are at an increased risk of developing lung cancer, suggests a study in Thorax.
Karolinska Development: Pharmanest AB today announced that the first patient has been dosed in an open label pharmacokinetic study with its drug candidate SHACT, a product developed for pain relief in connection with intrauterine device (IUD) insertion.
A team of researchers used several assays, atomic force microscopy, and simulations to determine that the N501Y mutation in the virus's receptor-binding domain (RBD) increased the interaction of the virus with the angiotensin-converting enzyme 2 (ACE2) receptor.
› Verified 2 days ago
Alexandra Marie Gomez, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1417 116th Ave Ne, Suite 110, Bellevue, WA 98004 Phone: 425-688-5900 Fax: 425-688-5912 | |
Elise Morrison, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5150 Village Park Dr Se, Bellevue, WA 98006 Phone: 425-657-0620 Fax: 425-502-8425 | |
Andrea Nicole Jamieson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16120 Ne 8th St, Bellevue, WA 98008 Phone: 425-747-4004 Fax: 425-747-1069 | |
Mrs. Katherine Jeanne Oberhofer, MS CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1417 116th Ave Ne Ste 110, Bellevue, WA 98004 Phone: 425-688-5911 Fax: 425-688-5912 | |
Mrs. Lori Anne Price, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12 Lummi Key, Bellevue, WA 98006 Phone: 425-643-2919 Fax: 425-657-0691 | |
Mackenzie Bush, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13333 Ne Bel Red Rd Ste 100, Bellevue, WA 98005 Phone: 501-352-0101 | |
Genenvieve Decantis, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5150 Village Park Dr Se, Bellevue, WA 98006 Phone: 425-657-0620 |